Kinase inactivation of GSK-3β, such as by the GSK-3β inhibitor AR79, promotes prostate cancer growth and mammary tumorigenesis by activating the canonical Wnt pathway [30, 31]. The gene discussed is GSK3B; the disease is Familial prostate cancer.